secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001104659-25-061751
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio stockholders elect all five director nominees and ratify Ernst & Young as auditor
--------------------------------------------------------------------------------

- 11,588,981 shares (59.47% of outstanding) represented at June 17, 2025 annual meeting.
- Directors Maccecchini, Hoffman, Bruck, McCarthy, White elected; broker non-votes ~7.2M each.
- Ratification of Ernst & Young LLP as independent auditor passed with 11,382,542 votes for.
- Auditor ratification had 187,959 against and 18,480 abstain; no other proposals voted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465925061751/0001104659-25-061751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465925061751/tm2518658d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer